Matarin Capital Management’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-90,668
Closed -$213K 220
2020
Q1
$213K Buy
90,668
+4,154
+5% +$26.9K 0.03% 198
2019
Q4
$908K Sell
86,514
-146,690
-63% -$1.33M 0.09% 192
2019
Q3
$1.99M Buy
233,204
+62,464
+37% +$613K 0.15% 172
2019
Q2
$1.97M Buy
170,740
+112,151
+191% +$1.44M 0.14% 178
2019
Q1
$821K Buy
+58,589
New +$768K 0.06% 224
2016
Q3
Sell
-43,345
Closed -$924K 249
2016
Q2
$924K Sell
43,345
-30,841
-42% -$581K 0.13% 179
2016
Q1
$1.31M Hold
74,186
0.18% 160
2015
Q4
$1.12M Hold
74,186
0.17% 159
2015
Q3
$975K Buy
+74,186
New +$1.18M 0.2% 142

Other funds holding PTEN

Matarin Capital Management's PTEN Position: Q2 2020 in Review

Matarin Capital Management sold out of Patterson-UTI (PTEN) in Q2 2020, closing a stake of 90,668 shares — an estimated $213K sold.

Matarin Capital Management first reported a position in PTEN in Q3 2015 and held it in 9 quarters. The position peaked at $1.99M in Q3 2019. 233 funds tracked by Wall St. Rank hold PTEN as of Q2 2020.

  • Matarin Capital Management reported no remaining Patterson-UTI position as of Q2 2020 after selling out during the quarter.
  • Matarin Capital Management sold 90,668 Patterson-UTI shares in Q2 2020, an estimated $213K.
  • Matarin Capital Management first reported a position in Patterson-UTI in Q3 2015 and held it in 9 quarters.
  • Matarin Capital Management's Patterson-UTI position peaked at $1.99M in Q3 2019.
  • 233 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2020.

Based on Matarin Capital Management's 13F filing for Q2 2020, filed 6 Aug 2020.